前往化源商城

β-Casomorphin (1-5) (bovine)

β-Casomorphin (1-5) (bovine)结构式
β-Casomorphin (1-5) (bovine)结构式
品牌特惠专场
常用名 β-Casomorphin (1-5) (bovine) 英文名 β-Casomorphin (1-5) (bovine) acetate salt
CAS号 72122-63-5 分子量 579.64
密度 1.362 g/cm3 沸点 1002.4ºC at 760 mmHg
分子式 C30H37N5O7 熔点 230ºC
MSDS 美版 闪点 560ºC

Tyr-c[D-Orn-Tyr(Bzl)-Pro-Gly]: a novel antiproliferative acting somatostatin receptor agonist with mu-opioid receptor-sensitizing properties.

Br. J. Pharmacol. 140(1) , 13-22, (2003)

(1) Here, we introduce a beta-casomorphin-5-derived cyclic pentapeptide, cCD-2 (Tyr-cyclo[d-Orn-Tyr(Bzl)-Pro-Gly]), which inhibits the cell growth of a variety of human cancer cell lines. (2) This opioid-derived peptide possesses only low affinity for mu-rece...

Metabolism of D-proline beta-casomorphin derivatives in the rat brain.

Biomed. Biochim. Acta 47(9) , 865-9, (1988)

The aim of the present study was to evaluate the metabolic breakdown of two biologically active derivatives of beta-casomorphin (beta CM)-i.e. D-proline4-beta CM (D-Pro4-beta CM) and des-tyrosine 1-D-proline4-beta CM (DT-D-Pro4-beta CM)- in the rat brain. Aft...

[Synthesis and biological activity of new analogs of beta-casomorphine-5].

Bioorg. Khim. 20(7) , 740-50, (1994)

Four new analogues of beta-cazomorphine-5 modified at the C-end with ethylenediamine- and glycine-containing derivatives were synthesized by the standard method of peptide chemistry (mixed anhydrides, carbodiimide, activated esters): H-Tyr-Pro-Phe-Pro-Gly-EtD...

Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.

Biopolymers 32(8) , 957-69, (1992)

In order to prevent enzymatic degradation of beta-casomorphin-5 (1) and morphiceptin, reduced peptide bonds were incorporated at the 2-3 and 3-4 bonds, respectively. The analogues were synthesized by a combination of solid phase methodology and reductive alky...

Assignment of the 1H-NMR resonances of the four rotamers of beta-casomorphin-5 in DMSO.

Biopolymers 31(12) , 1409-16, (1991)

We report the complete assignment of the 1H-nmr spectrum of beta-casomorphin-5 in DMSO-d6 solution. With a combination of one-dimensional, double quantum filtered correlated spectroscopy, homonuclear Hartmann-Hahn, and rotating frame nuclear Overhauser enhanc...

Nonopioid effects of beta-casomorphin-5 in guinea pig heart: alterations to the beta-adrenoceptor-G-protein complex and inhibition of myocardial responses to isoproterenol.

Peptides 12(2) , 265-70, (1991)

The influence of beta-casomorphin-5 on the beta-adrenoceptor complex in guinea pig heart membranes was studied by means of binding studies, G-protein investigations and isolated heart preparations. In nanomolar concentrations beta-CM-5 induced an increase in ...

Phe1-substituted beta-casomorphin-5 analogues with analgesic activity.

Peptides 15(3) , 457-60, (1994)

The antinociceptive potency of linear and cyclic beta-casomorphin-5 (CM-5) analogues, modified in position 1 by substitution of the tyrosine (Tyr) by the phenylalanine (Phe) residue, was studied using the vocalization test. With the exception of the linear [P...

Effects of beta-casomorphin-5 on passive avoidance response in mice.

Biosci. Biotechnol. Biochem. 67(11) , 2501-4, (2003)

The effects of intracerebroventricular (i.c.v.) injection of bovine beta-casomorphin-5 (beta-CM-5: Tyr-Pro-Phe-Pro-Gly), a micro-opioid agonist derived from milk beta-casein, on step-down type passive avoidance tasks were investigated in mice. Intracerebroven...

Structure-activity studies of novel casomorphin analogues: binding profiles towards mu 1-, mu 2- and delta -opioid receptors.

Pharmazie 46(5) , 345-8, (1991)

The beta -casomorphin-5 sequence was systematically modified by substitution of the naturally occurring amino acids. The derivatives are compared on the basis of their affinities towards mu 1-, mu 2 and delta -opioid binding sites estimated by means of bindin...

Effects of beta-casomorphin on 3H-ouabain binding to guinea pig heart membranes.

Pharmazie 41(9) , 670-1, (1986)